Risk of classical Kaposi sarcoma by plasma levels of Epstein-Barr virus antibodies, sCD26, sCD23 and sCD30

BACKGROUND: To clarify the immunological alterations leading to classical Kaposi sarcoma (cKS) among people infected with KS-associated herpesvirus (KSHV). METHODS: In a population-based study of 119 cKS cases, 105 KSHV-seropositive controls, and 155 KSHV-seronegative controls, we quantified plasma...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Pelser, Colleen, Middeldorp, Jaap, Mbulaiteye, Sam M, Lauria, Carmela, Messina, Angelo, Viviano, Enza, Romano, Nino, Vitale, Francesco, Goedert, James J
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2964600/
https://ncbi.nlm.nih.gov/pubmed/20939920
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1750-9378-5-18
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares